Chemistry:Selatogrel

From HandWiki

Selatogrel is a P2Y12 inhibitor[1][2] that has been proposed as a treatment for acute myocardial infarction.[3]

References

  1. ↑ "Selatogrel, a novel P2Y12 inhibitor: a review of the pharmacology and clinical development". Expert Opinion on Investigational Drugs 29 (6): 537–546. June 2020. doi:10.1080/13543784.2020.1764533. PMID 32396484. 
  2. ↑ "Pharmacology and potential role of selatogrel, a subcutaneous platelet P2Y12 receptor antagonist". Expert Opinion on Emerging Drugs 25 (1): 1–6. March 2020. doi:10.1080/14728214.2020.1729121. PMID 32064955. 
  3. ↑ "Clinical pharmacology of selatogrel for self-administration by patients with suspected acute myocardial infarction". Expert Opinion on Drug Metabolism & Toxicology 19 (10): 697–708. 2023. doi:10.1080/17425255.2023.2266384. PMID 37795868. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Selatogrel&oldid=4179647"